Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-12-001429
Filing Date
2012-10-15
Accepted
2012-10-15 17:03:34
Documents
11
Period of Report
2012-08-31

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 734251
2 ex31-1.htm EX-31.1 63381
3 ex31_2.htm EX-31.2 63279
4 ex32_1.htm EX-32.1 10011
5 ex32_2.htm EX-32.2 5614
  Complete submission text file 0001493152-12-001429.txt   4347129

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE kdmp-20120831.xml EX-101.INS 419951
7 XBRL SCHEMA FILE kdmp-20120831.xsd EX-101.SCH 45993
8 XBRL CALCULATION FILE kdmp-20120831_cal.xml EX-101.CAL 63322
9 XBRL DEFINITION FILE kdmp-20120831_def.xml EX-101.DEF 99069
10 XBRL LABEL FILE kdmp-20120831_lab.xml EX-101.LAB 338153
11 XBRL PRESENTATION FILE kdmp-20120831_pre.xml EX-101.PRE 228154
Mailing Address 885 WEST GEORGIA STREET SUITE 1500 VANCOUVER A1 V6C 3E8
Business Address 885 WEST GEORGIA STREET SUITE 1500 VANCOUVER A1 V6C 3E8 604-324-4844
Kedem Pharmaceuticals Inc. (Filer) CIK: 0001376228 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-54455 | Film No.: 121144343
SIC: 7819 Services-Allied To Motion Picture Production